ONKI3 | Medical Subject Headings

1. Val av ontologi/vokabulär

Med hjälp av ONKI-bläddraren kan du lätt bekanta dig med olika ontologier och vokabulärer. Du kan välja att använda någon av dessa genom att integrera din applikation i ONKI-servicen eller så kan du alternativt ladda innehållet i en ontologi/vokabulär via ONKI-bläddraren och använda det i din applikation på det sätt som ontologins/vokabulärens användarvillkor tillåter.

Du kan också skapa en egen ontologi/vokabulär och ladda in den i ONKI-servicen. En ontologi/vokabulär som du vill ladda in kan du antingen skapa från början eller så kan du bearbeta en ontologi/vokabulär som redan finns i ONKI. Som format för en ontologi/vokabulär som ska laddas in i ONKI kan du använda antingen SKOS- eller OWL-formatet. Tjänstens upprätthållare rekommenderar SKOS-formatet som framställningssätt för ordlistor och klassificeringar, medan det för mera omfattande ontologier torde vara bäst att använda OWL-språket. Ontologi/vokabulär -filen kan du hämta till ONKI-servicen via laddnings. När du har fyllt i formuläret publiceras din ontologi/vokabulär i ONKI-servicen inom några vardagar.

2. Användning av ONKI-servicen vid informationssökning och innehållsbeskrivning

Användning av ONKI-servicen vid informationssökning och/eller innehållsbeskrivning är gratis men kräver registrering. De uppgifter som ombeds vid registreringen används för att få en helhetsbild av vilka tjänster och hur mycket dessa tjänster används och av vem. Vi kan också utnyttja e-postadresserna för att informera stadigvarande användare om viktiga förändringar i anslutning till tjänsten.

ONKI-väljaren

I formuläret som du gör för informationssökning och innehållsbeskrivning kan ONKI-bläddraren användas som ett intelligent textbox-fält. När användaren skriver text i fältet erbjuder ONKI-systemet färdiga alternativ under fältet. Alternativens avgränsning baserar sig på de valbara begreppens stavning och de kan begränsas med hjälp av jokertecken i ONKI-systemet. Alternativen hämtas ur ontologierna/vokabulärerna som är publicerade i ONKI-systemet, beroende på de användarinställningar som du definierat i formuläret.

Vid innehållsbeskrivning kan du vara inriktad på valet av ett begrepp (t.ex. en typ av museiföremål: yxor), men vid informationssökning kan du använda utvidgad sökning med ontologins relationsinformation. Till exempel när man väljer sökordet verktyg som sökvillkor i museiföremålens sökformulär så kan man automatiskt lägga till bl.a. följande söktermer: yxor, cirklar, mejslar, o.s.v.

Maskinella gränssnitt

Via maskinella gränssnitt (Web service och HTTP) kan du utnyttja ONKI mer flexibelt. Behov av flexibilitet fanns bl.a. i SAHA metadata-editorn som utvecklades i SeCo och vid genomförandet kom man fram till att utnyttja gränssnittet för ONKIs web service. Via Web service-gränssnittet kan du ta reda på bl.a. namn som motsvarar begreppens URI på olika språk. Du kan bekanta dig med användning av gränssnittet via testsidan.

Ontologiservicen ONKI är en nationell tjänst som skapats av forskningsgruppen för semantisk beräkning (SeCo) som fungerar vid Aalto-universitetets högskola för teknikvetenskaper och Helsingfors universitet. Tjänsten har utvecklats inom ramen för projekten FinnONTO och FinnONTO 2.0. För utvecklandet av ONKI ansvarar SeCo:s ONKI-arbetsgrupp, till vilken hör:

Jouni Tuominen, doktorand
Eero Hyvönen, professor

Tidigare medlemmar: Kim Viljanen, Rami Alatalo

Tilläggsuppgifter om ONKI

suomeksi på svenska in English

Visningssätt för begreppens/termernas förhållanden: under varandra bredvid varandra

Det sätt begreppsrelationer visas: separat i hierarkin

CD59-antigener

Laddar resultat...


Hierarki:	Medical Subject Headings (MeSH) ∟ Amino Acids, Peptides, and Proteins ∟ Proteins ∟ Glycoproteins ∟ Membrane Glycoproteins ∟ CD59-antigener 131 sidobegrepp ∟ 4-1BB Ligand \| ∟ Antigens, CD147 \| ∟ Antigens, CD47 \| ∟ Antigens, CD55 \| ∟ Antigens, CD58 \| ∟ Antigens, CD70 \| ∟ Antigens, CD86 \| ∟ Antigens, Thy-1 \| ∟ Antiporters \| ∟ ATP-Binding Cassette Transporters \| ∟ B-Cell Activating Factor \| ∟ CA-15-3 Antigen \| ∟ CD30 Ligand \| ∟ CD40 Ligand \| ∟ Cell Adhesion Molecules \| ∟ Ectodysplasins \| ∟ Fas Ligand Protein \| ∟ Fibronectins \| ∟ GAP-43 Protein \| ∟ Glypicans \| ∟ Ion Channels \| ∟ Kangai-1 Protein \| ∟ Laminin \| ∟ Lysosome-Associated Membrane Glycoproteins \| ∟ Myelin-Associated Glycoprotein \| ∟ OX40 Ligand \| ∟ PHEX Phosphate Regulating Neutral Endopeptidase \| ∟ Platelet Membrane Glycoproteins \| ∟ Sarcoglycans \| ∟ Synaptophysin \| ∟ Syndecans \| ∟ Thrombospondins \| ∟ Variant Surface Glycoproteins, Trypanosoma \| ∟ 5'-Nucleotidase \| ∟ Activated-Leukocyte Cell Adhesion Molecule \| ∟ Antigens, CD1 \| ∟ Antigens, CD11 \| ∟ Antigens, CD13 \| ∟ Antigens, CD137 \| ∟ Antigens, CD14 \| ∟ Antigens, CD146 \| ∟ Antigens, CD15 \| ∟ Antigens, CD164 \| ∟ Antigens, CD18 \| ∟ Antigens, CD19 \| ∟ Antigens, CD2 \| ∟ Antigens, CD20 \| ∟ Antigens, CD22 \| ∟ Antigens, CD24 \| ∟ Antigens, CD26 \| ∟ Antigens, CD27 \| ∟ Antigens, CD28 \| ∟ Antigens, CD29 \| ∟ Antigens, CD3 \| ∟ Antigens, CD30 \| ∟ Antigens, CD31 \| ∟ Antigens, CD34 \| ∟ Antigens, CD36 \| ∟ Antigens, CD38 \| ∟ Antigens, CD4 \| ∟ Antigens, CD40 \| ∟ Antigens, CD43 \| ∟ Antigens, CD45 \| ∟ Antigens, CD46 \| ∟ Antigens, CD5 \| ∟ Antigens, CD56 \| ∟ Antigens, CD57 \| ∟ Antigens, CD7 \| ∟ Antigens, CD79 \| ∟ Antigens, CD8 \| ∟ Antigens, CD80 \| ∟ Antigens, CD94 \| ∟ Antigens, CD95 \| ∟ Antigens, CD98 \| ∟ B-Cell Activation Factor Receptor \| ∟ Cytokine Receptor Common beta Subunit \| ∟ Cytokine Receptor gp130 \| ∟ E-Selectin \| ∟ fms-Like Tyrosine Kinase 3 \| ∟ Integrin alpha1 \| ∟ Integrin alpha2 \| ∟ Integrin alpha3 \| ∟ Integrin alpha4 \| ∟ Integrin alpha5 \| ∟ Integrin alpha6 \| ∟ Integrin alphaV \| ∟ Integrin beta3 \| ∟ Integrin beta4 \| ∟ Intercellular Adhesion Molecule-1 \| ∟ Interleukin Receptor Common gamma Subunit \| ∟ Interleukin-10 Receptor alpha Subunit \| ∟ Interleukin-10 Receptor beta Subunit \| ∟ Interleukin-13 Receptor alpha1 Subunit \| ∟ Interleukin-13 Receptor alpha2 Subunit \| ∟ Interleukin-18 Receptor alpha Subunit \| ∟ Interleukin-18 Receptor beta Subunit \| ∟ Interleukin-2 Receptor alpha Subunit \| ∟ Interleukin-2 Receptor beta Subunit \| ∟ Interleukin-3 Receptor alpha Subunit \| ∟ Interleukin-4 Receptor alpha Subunit \| ∟ Interleukin-5 Receptor alpha Subunit \| ∟ Interleukin-6 Receptor alpha Subunit \| ∟ Interleukin-7 Receptor alpha Subunit \| ∟ Leukemia Inhibitory Factor Receptor alpha Subunit \| ∟ Lysosomal-Associated Membrane Protein 1 \| ∟ Lysosomal-Associated Membrane Protein 2 \| ∟ Neprilysin \| ∟ P-Selectin \| ∟ Peptidyl-Dipeptidase A \| ∟ Platelet Membrane Glycoprotein IIb \| ∟ Proto-Oncogene Proteins c-kit \| ∟ Receptor, Anaphylatoxin C5a \| ∟ Receptor, Macrophage Colony-Stimulating Factor \| ∟ Receptors, Complement 3b \| ∟ Receptors, Complement 3d \| ∟ Receptors, IgE \| ∟ Receptors, IgG \| ∟ Receptors, Interleukin-1 Type I \| ∟ Receptors, Interleukin-1 Type II \| ∟ Receptors, Interleukin-17 \| ∟ Receptors, Interleukin-7 \| ∟ Receptors, Interleukin-8A \| ∟ Receptors, Interleukin-9 \| ∟ Receptors, Lymphocyte Homing \| ∟ Receptors, OX40 \| ∟ Receptors, Thrombopoietin \| ∟ Receptors, Tumor Necrosis Factor, Type I \| ∟ Receptors, Tumor Necrosis Factor, Type II \| ∟ Syndecan-1 \| ∟ Transmembrane Activator and CAML Interactor Protein \| ∟ Vascular Cell Adhesion Molecule-1 Medical Subject Headings (MeSH) ∟ Amino Acids, Peptides, and Proteins ∟ Proteins ∟ Membrane Proteins ∟ Membrane Glycoproteins ∟ CD59-antigener 131 sidobegrepp ∟ 4-1BB Ligand \| ∟ Antigens, CD147 \| ∟ Antigens, CD47 \| ∟ Antigens, CD55 \| ∟ Antigens, CD58 \| ∟ Antigens, CD70 \| ∟ Antigens, CD86 \| ∟ Antigens, Thy-1 \| ∟ Antiporters \| ∟ ATP-Binding Cassette Transporters \| ∟ B-Cell Activating Factor \| ∟ CA-15-3 Antigen \| ∟ CD30 Ligand \| ∟ CD40 Ligand \| ∟ Cell Adhesion Molecules \| ∟ Ectodysplasins \| ∟ Fas Ligand Protein \| ∟ Fibronectins \| ∟ GAP-43 Protein \| ∟ Glypicans \| ∟ Ion Channels \| ∟ Kangai-1 Protein \| ∟ Laminin \| ∟ Lysosome-Associated Membrane Glycoproteins \| ∟ Myelin-Associated Glycoprotein \| ∟ OX40 Ligand \| ∟ PHEX Phosphate Regulating Neutral Endopeptidase \| ∟ Platelet Membrane Glycoproteins \| ∟ Sarcoglycans \| ∟ Synaptophysin \| ∟ Syndecans \| ∟ Thrombospondins \| ∟ Variant Surface Glycoproteins, Trypanosoma \| ∟ 5'-Nucleotidase \| ∟ Activated-Leukocyte Cell Adhesion Molecule \| ∟ Antigens, CD1 \| ∟ Antigens, CD11 \| ∟ Antigens, CD13 \| ∟ Antigens, CD137 \| ∟ Antigens, CD14 \| ∟ Antigens, CD146 \| ∟ Antigens, CD15 \| ∟ Antigens, CD164 \| ∟ Antigens, CD18 \| ∟ Antigens, CD19 \| ∟ Antigens, CD2 \| ∟ Antigens, CD20 \| ∟ Antigens, CD22 \| ∟ Antigens, CD24 \| ∟ Antigens, CD26 \| ∟ Antigens, CD27 \| ∟ Antigens, CD28 \| ∟ Antigens, CD29 \| ∟ Antigens, CD3 \| ∟ Antigens, CD30 \| ∟ Antigens, CD31 \| ∟ Antigens, CD34 \| ∟ Antigens, CD36 \| ∟ Antigens, CD38 \| ∟ Antigens, CD4 \| ∟ Antigens, CD40 \| ∟ Antigens, CD43 \| ∟ Antigens, CD45 \| ∟ Antigens, CD46 \| ∟ Antigens, CD5 \| ∟ Antigens, CD56 \| ∟ Antigens, CD57 \| ∟ Antigens, CD7 \| ∟ Antigens, CD79 \| ∟ Antigens, CD8 \| ∟ Antigens, CD80 \| ∟ Antigens, CD94 \| ∟ Antigens, CD95 \| ∟ Antigens, CD98 \| ∟ B-Cell Activation Factor Receptor \| ∟ Cytokine Receptor Common beta Subunit \| ∟ Cytokine Receptor gp130 \| ∟ E-Selectin \| ∟ fms-Like Tyrosine Kinase 3 \| ∟ Integrin alpha1 \| ∟ Integrin alpha2 \| ∟ Integrin alpha3 \| ∟ Integrin alpha4 \| ∟ Integrin alpha5 \| ∟ Integrin alpha6 \| ∟ Integrin alphaV \| ∟ Integrin beta3 \| ∟ Integrin beta4 \| ∟ Intercellular Adhesion Molecule-1 \| ∟ Interleukin Receptor Common gamma Subunit \| ∟ Interleukin-10 Receptor alpha Subunit \| ∟ Interleukin-10 Receptor beta Subunit \| ∟ Interleukin-13 Receptor alpha1 Subunit \| ∟ Interleukin-13 Receptor alpha2 Subunit \| ∟ Interleukin-18 Receptor alpha Subunit \| ∟ Interleukin-18 Receptor beta Subunit \| ∟ Interleukin-2 Receptor alpha Subunit \| ∟ Interleukin-2 Receptor beta Subunit \| ∟ Interleukin-3 Receptor alpha Subunit \| ∟ Interleukin-4 Receptor alpha Subunit \| ∟ Interleukin-5 Receptor alpha Subunit \| ∟ Interleukin-6 Receptor alpha Subunit \| ∟ Interleukin-7 Receptor alpha Subunit \| ∟ Leukemia Inhibitory Factor Receptor alpha Subunit \| ∟ Lysosomal-Associated Membrane Protein 1 \| ∟ Lysosomal-Associated Membrane Protein 2 \| ∟ Neprilysin \| ∟ P-Selectin \| ∟ Peptidyl-Dipeptidase A \| ∟ Platelet Membrane Glycoprotein IIb \| ∟ Proto-Oncogene Proteins c-kit \| ∟ Receptor, Anaphylatoxin C5a \| ∟ Receptor, Macrophage Colony-Stimulating Factor \| ∟ Receptors, Complement 3b \| ∟ Receptors, Complement 3d \| ∟ Receptors, IgE \| ∟ Receptors, IgG \| ∟ Receptors, Interleukin-1 Type I \| ∟ Receptors, Interleukin-1 Type II \| ∟ Receptors, Interleukin-17 \| ∟ Receptors, Interleukin-7 \| ∟ Receptors, Interleukin-8A \| ∟ Receptors, Interleukin-9 \| ∟ Receptors, Lymphocyte Homing \| ∟ Receptors, OX40 \| ∟ Receptors, Thrombopoietin \| ∟ Receptors, Tumor Necrosis Factor, Type I \| ∟ Receptors, Tumor Necrosis Factor, Type II \| ∟ Syndecan-1 \| ∟ Transmembrane Activator and CAML Interactor Protein \| ∟ Vascular Cell Adhesion Molecule-1 Medical Subject Headings (MeSH) ∟ Biological Factors ∟ Antigens ∟ Antigens, Surface ∟ Antigens, Differentiation ∟ Antigens, CD ∟ CD59-antigener 131 sidobegrepp ∟ 4-1BB Ligand \| ∟ Antigens, CD147 \| ∟ Antigens, CD47 \| ∟ Antigens, CD55 \| ∟ Antigens, CD58 \| ∟ Antigens, CD70 \| ∟ Antigens, CD86 \| ∟ Antigens, Thy-1 \| ∟ Antiporters \| ∟ ATP-Binding Cassette Transporters \| ∟ B-Cell Activating Factor \| ∟ CA-15-3 Antigen \| ∟ CD30 Ligand \| ∟ CD40 Ligand \| ∟ Cell Adhesion Molecules \| ∟ Ectodysplasins \| ∟ Fas Ligand Protein \| ∟ Fibronectins \| ∟ GAP-43 Protein \| ∟ Glypicans \| ∟ Ion Channels \| ∟ Kangai-1 Protein \| ∟ Laminin \| ∟ Lysosome-Associated Membrane Glycoproteins \| ∟ Myelin-Associated Glycoprotein \| ∟ OX40 Ligand \| ∟ PHEX Phosphate Regulating Neutral Endopeptidase \| ∟ Platelet Membrane Glycoproteins \| ∟ Sarcoglycans \| ∟ Synaptophysin \| ∟ Syndecans \| ∟ Thrombospondins \| ∟ Variant Surface Glycoproteins, Trypanosoma \| ∟ 5'-Nucleotidase \| ∟ Activated-Leukocyte Cell Adhesion Molecule \| ∟ Antigens, CD1 \| ∟ Antigens, CD11 \| ∟ Antigens, CD13 \| ∟ Antigens, CD137 \| ∟ Antigens, CD14 \| ∟ Antigens, CD146 \| ∟ Antigens, CD15 \| ∟ Antigens, CD164 \| ∟ Antigens, CD18 \| ∟ Antigens, CD19 \| ∟ Antigens, CD2 \| ∟ Antigens, CD20 \| ∟ Antigens, CD22 \| ∟ Antigens, CD24 \| ∟ Antigens, CD26 \| ∟ Antigens, CD27 \| ∟ Antigens, CD28 \| ∟ Antigens, CD29 \| ∟ Antigens, CD3 \| ∟ Antigens, CD30 \| ∟ Antigens, CD31 \| ∟ Antigens, CD34 \| ∟ Antigens, CD36 \| ∟ Antigens, CD38 \| ∟ Antigens, CD4 \| ∟ Antigens, CD40 \| ∟ Antigens, CD43 \| ∟ Antigens, CD45 \| ∟ Antigens, CD46 \| ∟ Antigens, CD5 \| ∟ Antigens, CD56 \| ∟ Antigens, CD57 \| ∟ Antigens, CD7 \| ∟ Antigens, CD79 \| ∟ Antigens, CD8 \| ∟ Antigens, CD80 \| ∟ Antigens, CD94 \| ∟ Antigens, CD95 \| ∟ Antigens, CD98 \| ∟ B-Cell Activation Factor Receptor \| ∟ Cytokine Receptor Common beta Subunit \| ∟ Cytokine Receptor gp130 \| ∟ E-Selectin \| ∟ fms-Like Tyrosine Kinase 3 \| ∟ Integrin alpha1 \| ∟ Integrin alpha2 \| ∟ Integrin alpha3 \| ∟ Integrin alpha4 \| ∟ Integrin alpha5 \| ∟ Integrin alpha6 \| ∟ Integrin alphaV \| ∟ Integrin beta3 \| ∟ Integrin beta4 \| ∟ Intercellular Adhesion Molecule-1 \| ∟ Interleukin Receptor Common gamma Subunit \| ∟ Interleukin-10 Receptor alpha Subunit \| ∟ Interleukin-10 Receptor beta Subunit \| ∟ Interleukin-13 Receptor alpha1 Subunit \| ∟ Interleukin-13 Receptor alpha2 Subunit \| ∟ Interleukin-18 Receptor alpha Subunit \| ∟ Interleukin-18 Receptor beta Subunit \| ∟ Interleukin-2 Receptor alpha Subunit \| ∟ Interleukin-2 Receptor beta Subunit \| ∟ Interleukin-3 Receptor alpha Subunit \| ∟ Interleukin-4 Receptor alpha Subunit \| ∟ Interleukin-5 Receptor alpha Subunit \| ∟ Interleukin-6 Receptor alpha Subunit \| ∟ Interleukin-7 Receptor alpha Subunit \| ∟ Leukemia Inhibitory Factor Receptor alpha Subunit \| ∟ Lysosomal-Associated Membrane Protein 1 \| ∟ Lysosomal-Associated Membrane Protein 2 \| ∟ Neprilysin \| ∟ P-Selectin \| ∟ Peptidyl-Dipeptidase A \| ∟ Platelet Membrane Glycoprotein IIb \| ∟ Proto-Oncogene Proteins c-kit \| ∟ Receptor, Anaphylatoxin C5a \| ∟ Receptor, Macrophage Colony-Stimulating Factor \| ∟ Receptors, Complement 3b \| ∟ Receptors, Complement 3d \| ∟ Receptors, IgE \| ∟ Receptors, IgG \| ∟ Receptors, Interleukin-1 Type I \| ∟ Receptors, Interleukin-1 Type II \| ∟ Receptors, Interleukin-17 \| ∟ Receptors, Interleukin-7 \| ∟ Receptors, Interleukin-8A \| ∟ Receptors, Interleukin-9 \| ∟ Receptors, Lymphocyte Homing \| ∟ Receptors, OX40 \| ∟ Receptors, Thrombopoietin \| ∟ Receptors, Tumor Necrosis Factor, Type I \| ∟ Receptors, Tumor Necrosis Factor, Type II \| ∟ Syndecan-1 \| ∟ Transmembrane Activator and CAML Interactor Protein \| ∟ Vascular Cell Adhesion Molecule-1 Medical Subject Headings (MeSH) ∟ Biological Factors ∟ Biological Markers ∟ Antigens, Differentiation ∟ Antigens, CD ∟ CD59-antigener 131 sidobegrepp ∟ 4-1BB Ligand \| ∟ Antigens, CD147 \| ∟ Antigens, CD47 \| ∟ Antigens, CD55 \| ∟ Antigens, CD58 \| ∟ Antigens, CD70 \| ∟ Antigens, CD86 \| ∟ Antigens, Thy-1 \| ∟ Antiporters \| ∟ ATP-Binding Cassette Transporters \| ∟ B-Cell Activating Factor \| ∟ CA-15-3 Antigen \| ∟ CD30 Ligand \| ∟ CD40 Ligand \| ∟ Cell Adhesion Molecules \| ∟ Ectodysplasins \| ∟ Fas Ligand Protein \| ∟ Fibronectins \| ∟ GAP-43 Protein \| ∟ Glypicans \| ∟ Ion Channels \| ∟ Kangai-1 Protein \| ∟ Laminin \| ∟ Lysosome-Associated Membrane Glycoproteins \| ∟ Myelin-Associated Glycoprotein \| ∟ OX40 Ligand \| ∟ PHEX Phosphate Regulating Neutral Endopeptidase \| ∟ Platelet Membrane Glycoproteins \| ∟ Sarcoglycans \| ∟ Synaptophysin \| ∟ Syndecans \| ∟ Thrombospondins \| ∟ Variant Surface Glycoproteins, Trypanosoma \| ∟ 5'-Nucleotidase \| ∟ Activated-Leukocyte Cell Adhesion Molecule \| ∟ Antigens, CD1 \| ∟ Antigens, CD11 \| ∟ Antigens, CD13 \| ∟ Antigens, CD137 \| ∟ Antigens, CD14 \| ∟ Antigens, CD146 \| ∟ Antigens, CD15 \| ∟ Antigens, CD164 \| ∟ Antigens, CD18 \| ∟ Antigens, CD19 \| ∟ Antigens, CD2 \| ∟ Antigens, CD20 \| ∟ Antigens, CD22 \| ∟ Antigens, CD24 \| ∟ Antigens, CD26 \| ∟ Antigens, CD27 \| ∟ Antigens, CD28 \| ∟ Antigens, CD29 \| ∟ Antigens, CD3 \| ∟ Antigens, CD30 \| ∟ Antigens, CD31 \| ∟ Antigens, CD34 \| ∟ Antigens, CD36 \| ∟ Antigens, CD38 \| ∟ Antigens, CD4 \| ∟ Antigens, CD40 \| ∟ Antigens, CD43 \| ∟ Antigens, CD45 \| ∟ Antigens, CD46 \| ∟ Antigens, CD5 \| ∟ Antigens, CD56 \| ∟ Antigens, CD57 \| ∟ Antigens, CD7 \| ∟ Antigens, CD79 \| ∟ Antigens, CD8 \| ∟ Antigens, CD80 \| ∟ Antigens, CD94 \| ∟ Antigens, CD95 \| ∟ Antigens, CD98 \| ∟ B-Cell Activation Factor Receptor \| ∟ Cytokine Receptor Common beta Subunit \| ∟ Cytokine Receptor gp130 \| ∟ E-Selectin \| ∟ fms-Like Tyrosine Kinase 3 \| ∟ Integrin alpha1 \| ∟ Integrin alpha2 \| ∟ Integrin alpha3 \| ∟ Integrin alpha4 \| ∟ Integrin alpha5 \| ∟ Integrin alpha6 \| ∟ Integrin alphaV \| ∟ Integrin beta3 \| ∟ Integrin beta4 \| ∟ Intercellular Adhesion Molecule-1 \| ∟ Interleukin Receptor Common gamma Subunit \| ∟ Interleukin-10 Receptor alpha Subunit \| ∟ Interleukin-10 Receptor beta Subunit \| ∟ Interleukin-13 Receptor alpha1 Subunit \| ∟ Interleukin-13 Receptor alpha2 Subunit \| ∟ Interleukin-18 Receptor alpha Subunit \| ∟ Interleukin-18 Receptor beta Subunit \| ∟ Interleukin-2 Receptor alpha Subunit \| ∟ Interleukin-2 Receptor beta Subunit \| ∟ Interleukin-3 Receptor alpha Subunit \| ∟ Interleukin-4 Receptor alpha Subunit \| ∟ Interleukin-5 Receptor alpha Subunit \| ∟ Interleukin-6 Receptor alpha Subunit \| ∟ Interleukin-7 Receptor alpha Subunit \| ∟ Leukemia Inhibitory Factor Receptor alpha Subunit \| ∟ Lysosomal-Associated Membrane Protein 1 \| ∟ Lysosomal-Associated Membrane Protein 2 \| ∟ Neprilysin \| ∟ P-Selectin \| ∟ Peptidyl-Dipeptidase A \| ∟ Platelet Membrane Glycoprotein IIb \| ∟ Proto-Oncogene Proteins c-kit \| ∟ Receptor, Anaphylatoxin C5a \| ∟ Receptor, Macrophage Colony-Stimulating Factor \| ∟ Receptors, Complement 3b \| ∟ Receptors, Complement 3d \| ∟ Receptors, IgE \| ∟ Receptors, IgG \| ∟ Receptors, Interleukin-1 Type I \| ∟ Receptors, Interleukin-1 Type II \| ∟ Receptors, Interleukin-17 \| ∟ Receptors, Interleukin-7 \| ∟ Receptors, Interleukin-8A \| ∟ Receptors, Interleukin-9 \| ∟ Receptors, Lymphocyte Homing \| ∟ Receptors, OX40 \| ∟ Receptors, Thrombopoietin \| ∟ Receptors, Tumor Necrosis Factor, Type I \| ∟ Receptors, Tumor Necrosis Factor, Type II \| ∟ Syndecan-1 \| ∟ Transmembrane Activator and CAML Interactor Protein \| ∟ Vascular Cell Adhesion Molecule-1 Medical Subject Headings (MeSH) ∟ Carbohydrates ∟ Glycoconjugates ∟ Glycoproteins ∟ Membrane Glycoproteins ∟ CD59-antigener 131 sidobegrepp ∟ 4-1BB Ligand \| ∟ Antigens, CD147 \| ∟ Antigens, CD47 \| ∟ Antigens, CD55 \| ∟ Antigens, CD58 \| ∟ Antigens, CD70 \| ∟ Antigens, CD86 \| ∟ Antigens, Thy-1 \| ∟ Antiporters \| ∟ ATP-Binding Cassette Transporters \| ∟ B-Cell Activating Factor \| ∟ CA-15-3 Antigen \| ∟ CD30 Ligand \| ∟ CD40 Ligand \| ∟ Cell Adhesion Molecules \| ∟ Ectodysplasins \| ∟ Fas Ligand Protein \| ∟ Fibronectins \| ∟ GAP-43 Protein \| ∟ Glypicans \| ∟ Ion Channels \| ∟ Kangai-1 Protein \| ∟ Laminin \| ∟ Lysosome-Associated Membrane Glycoproteins \| ∟ Myelin-Associated Glycoprotein \| ∟ OX40 Ligand \| ∟ PHEX Phosphate Regulating Neutral Endopeptidase \| ∟ Platelet Membrane Glycoproteins \| ∟ Sarcoglycans \| ∟ Synaptophysin \| ∟ Syndecans \| ∟ Thrombospondins \| ∟ Variant Surface Glycoproteins, Trypanosoma \| ∟ 5'-Nucleotidase \| ∟ Activated-Leukocyte Cell Adhesion Molecule \| ∟ Antigens, CD1 \| ∟ Antigens, CD11 \| ∟ Antigens, CD13 \| ∟ Antigens, CD137 \| ∟ Antigens, CD14 \| ∟ Antigens, CD146 \| ∟ Antigens, CD15 \| ∟ Antigens, CD164 \| ∟ Antigens, CD18 \| ∟ Antigens, CD19 \| ∟ Antigens, CD2 \| ∟ Antigens, CD20 \| ∟ Antigens, CD22 \| ∟ Antigens, CD24 \| ∟ Antigens, CD26 \| ∟ Antigens, CD27 \| ∟ Antigens, CD28 \| ∟ Antigens, CD29 \| ∟ Antigens, CD3 \| ∟ Antigens, CD30 \| ∟ Antigens, CD31 \| ∟ Antigens, CD34 \| ∟ Antigens, CD36 \| ∟ Antigens, CD38 \| ∟ Antigens, CD4 \| ∟ Antigens, CD40 \| ∟ Antigens, CD43 \| ∟ Antigens, CD45 \| ∟ Antigens, CD46 \| ∟ Antigens, CD5 \| ∟ Antigens, CD56 \| ∟ Antigens, CD57 \| ∟ Antigens, CD7 \| ∟ Antigens, CD79 \| ∟ Antigens, CD8 \| ∟ Antigens, CD80 \| ∟ Antigens, CD94 \| ∟ Antigens, CD95 \| ∟ Antigens, CD98 \| ∟ B-Cell Activation Factor Receptor \| ∟ Cytokine Receptor Common beta Subunit \| ∟ Cytokine Receptor gp130 \| ∟ E-Selectin \| ∟ fms-Like Tyrosine Kinase 3 \| ∟ Integrin alpha1 \| ∟ Integrin alpha2 \| ∟ Integrin alpha3 \| ∟ Integrin alpha4 \| ∟ Integrin alpha5 \| ∟ Integrin alpha6 \| ∟ Integrin alphaV \| ∟ Integrin beta3 \| ∟ Integrin beta4 \| ∟ Intercellular Adhesion Molecule-1 \| ∟ Interleukin Receptor Common gamma Subunit \| ∟ Interleukin-10 Receptor alpha Subunit \| ∟ Interleukin-10 Receptor beta Subunit \| ∟ Interleukin-13 Receptor alpha1 Subunit \| ∟ Interleukin-13 Receptor alpha2 Subunit \| ∟ Interleukin-18 Receptor alpha Subunit \| ∟ Interleukin-18 Receptor beta Subunit \| ∟ Interleukin-2 Receptor alpha Subunit \| ∟ Interleukin-2 Receptor beta Subunit \| ∟ Interleukin-3 Receptor alpha Subunit \| ∟ Interleukin-4 Receptor alpha Subunit \| ∟ Interleukin-5 Receptor alpha Subunit \| ∟ Interleukin-6 Receptor alpha Subunit \| ∟ Interleukin-7 Receptor alpha Subunit \| ∟ Leukemia Inhibitory Factor Receptor alpha Subunit \| ∟ Lysosomal-Associated Membrane Protein 1 \| ∟ Lysosomal-Associated Membrane Protein 2 \| ∟ Neprilysin \| ∟ P-Selectin \| ∟ Peptidyl-Dipeptidase A \| ∟ Platelet Membrane Glycoprotein IIb \| ∟ Proto-Oncogene Proteins c-kit \| ∟ Receptor, Anaphylatoxin C5a \| ∟ Receptor, Macrophage Colony-Stimulating Factor \| ∟ Receptors, Complement 3b \| ∟ Receptors, Complement 3d \| ∟ Receptors, IgE \| ∟ Receptors, IgG \| ∟ Receptors, Interleukin-1 Type I \| ∟ Receptors, Interleukin-1 Type II \| ∟ Receptors, Interleukin-17 \| ∟ Receptors, Interleukin-7 \| ∟ Receptors, Interleukin-8A \| ∟ Receptors, Interleukin-9 \| ∟ Receptors, Lymphocyte Homing \| ∟ Receptors, OX40 \| ∟ Receptors, Thrombopoietin \| ∟ Receptors, Tumor Necrosis Factor, Type I \| ∟ Receptors, Tumor Necrosis Factor, Type II \| ∟ Syndecan-1 \| ∟ Transmembrane Activator and CAML Interactor Protein \| ∟ Vascular Cell Adhesion Molecule-1 X
Bredare villkor:	Medical Subject Headings (MeSH) ∟ Amino Acids, Peptides, and Proteins ∟ Proteins ∟ Glycoproteins ∟ Membrane Glycoproteins ∟ CD59-antigener Medical Subject Headings (MeSH) ∟ Amino Acids, Peptides, and Proteins ∟ Proteins ∟ Membrane Proteins ∟ Membrane Glycoproteins ∟ CD59-antigener Medical Subject Headings (MeSH) ∟ Biological Factors ∟ Antigens ∟ Antigens, Surface ∟ Antigens, Differentiation ∟ Antigens, CD ∟ CD59-antigener Medical Subject Headings (MeSH) ∟ Biological Factors ∟ Biological Markers ∟ Antigens, Differentiation ∟ Antigens, CD ∟ CD59-antigener Medical Subject Headings (MeSH) ∟ Carbohydrates ∟ Glycoconjugates ∟ Glycoproteins ∟ Membrane Glycoproteins ∟ CD59-antigener Membrane Glycoproteins > Glycoproteins > Proteins > Amino Acids, Peptides, and Proteins > Medical Subject Headings (MeSH) Membrane Glycoproteins > Membrane Proteins > Proteins > Amino Acids, Peptides, and Proteins > Medical Subject Headings (MeSH) Antigens, CD > Antigens, Differentiation > Antigens, Surface > Antigens > Biological Factors > Medical Subject Headings (MeSH) Antigens, CD > Antigens, Differentiation > Biological Markers > Biological Factors > Medical Subject Headings (MeSH) Membrane Glycoproteins > Glycoproteins > Glycoconjugates > Carbohydrates > Medical Subject Headings (MeSH) X
Anmärkning:	Antigens, CD (1990-1995) \| Antigens, Differentiation (1989-1991) \| Membrane Glycoproteins (1989-1995)X
Anmärkning:	Small glycoproteins found on both hematopoietic and non-hematopoietic cells. CD59 restricts the cytolytic activity of homologous complement by binding to C8 and C9 and blocking the assembly of the membrane attack complex. (From Barclay et al., The Leukocyte Antigen FactsBook, 1993, p234) X
historyNote*:	1996; use CD59 ANTIGEN (NM) 1989-1995, for PROTECTIN use CATIONIC PROTEIN, URATE-CALCIUM OXALATE STONE (NM) 1996-1999 X
publicMeSHNote*:	1996; CD59 ANTIGEN was indexed under ANTIGENS, CD 1990-1995; MEMBRANE GLYCOPROTEINS 1989-1995; & ANTIGENS, DIFFERENTIATION 1989-1991; MEMBRANE ATTACK COMPLEX INHIBITION FACTOR (now ANTIGENS, CD59) was indexed under PROTEINS 1992-1997 & BLOOD PROTEINS 1990-1991; PROTECTIN was indexed under ION CHANNELS 1996-1999 X
activeMeSHYear*:	2006 \| 2007X
dateCreated*:	1995-05-26X
dateEstablished*:	1996-01-01X
dateRevised*:	2005-06-30X
recordAuthorizer*:	sjnX
recordMaintainer*:	ssbX
recordOriginator*:	AGSX
Typ:	Concept X
Samordna villkor:	4-1BB Ligand \| Antigens, CD147 \| Antigens, CD47 \| Antigens, CD55 \| Antigens, CD58 \| Antigens, CD70 \| Antigens, CD86 \| Antigens, Thy-1 \| Antiporters \| ATP-Binding Cassette Transporters \| B-Cell Activating Factor \| CA-15-3 Antigen \| CD30 Ligand \| CD40 Ligand \| Cell Adhesion Molecules \| Ectodysplasins \| Fas Ligand Protein \| Fibronectins \| GAP-43 Protein \| Glypicans \| Ion Channels \| Kangai-1 Protein \| Laminin \| Lysosome-Associated Membrane Glycoproteins \| Myelin-Associated Glycoprotein \| OX40 Ligand \| PHEX Phosphate Regulating Neutral Endopeptidase \| Platelet Membrane Glycoproteins \| Sarcoglycans \| Synaptophysin \| Syndecans \| Thrombospondins \| Variant Surface Glycoproteins, Trypanosoma \| 5'-Nucleotidase \| Activated-Leukocyte Cell Adhesion Molecule \| Antigens, CD1 \| Antigens, CD11 \| Antigens, CD13 \| Antigens, CD137 \| Antigens, CD14 \| Antigens, CD146 \| Antigens, CD15 \| Antigens, CD164 \| Antigens, CD18 \| Antigens, CD19 \| Antigens, CD2 \| Antigens, CD20 \| Antigens, CD22 \| Antigens, CD24 \| Antigens, CD26 \| Antigens, CD27 \| Antigens, CD28 \| Antigens, CD29 \| Antigens, CD3 \| Antigens, CD30 \| Antigens, CD31 \| Antigens, CD34 \| Antigens, CD36 \| Antigens, CD38 \| Antigens, CD4 \| Antigens, CD40 \| Antigens, CD43 \| Antigens, CD45 \| Antigens, CD46 \| Antigens, CD5 \| Antigens, CD56 \| Antigens, CD57 \| Antigens, CD7 \| Antigens, CD79 \| Antigens, CD8 \| Antigens, CD80 \| Antigens, CD94 \| Antigens, CD95 \| Antigens, CD98 \| B-Cell Activation Factor Receptor \| Cytokine Receptor Common beta Subunit \| Cytokine Receptor gp130 \| E-Selectin \| fms-Like Tyrosine Kinase 3 \| Integrin alpha1 \| Integrin alpha2 \| Integrin alpha3 \| Integrin alpha4 \| Integrin alpha5 \| Integrin alpha6 \| Integrin alphaV \| Integrin beta3 \| Integrin beta4 \| Intercellular Adhesion Molecule-1 \| Interleukin Receptor Common gamma Subunit \| Interleukin-10 Receptor alpha Subunit \| Interleukin-10 Receptor beta Subunit \| Interleukin-13 Receptor alpha1 Subunit \| Interleukin-13 Receptor alpha2 Subunit \| Interleukin-18 Receptor alpha Subunit \| Interleukin-18 Receptor beta Subunit \| Interleukin-2 Receptor alpha Subunit \| Interleukin-2 Receptor beta Subunit \| Interleukin-3 Receptor alpha Subunit \| Interleukin-4 Receptor alpha Subunit \| Interleukin-5 Receptor alpha Subunit \| Interleukin-6 Receptor alpha Subunit \| Interleukin-7 Receptor alpha Subunit \| Leukemia Inhibitory Factor Receptor alpha Subunit \| Lysosomal-Associated Membrane Protein 1 \| Lysosomal-Associated Membrane Protein 2 \| Neprilysin \| P-Selectin \| Peptidyl-Dipeptidase A \| Platelet Membrane Glycoprotein IIb \| Proto-Oncogene Proteins c-kit \| Receptor, Anaphylatoxin C5a \| Receptor, Macrophage Colony-Stimulating Factor \| Receptors, Complement 3b \| Receptors, Complement 3d \| Receptors, IgE \| Receptors, IgG \| Receptors, Interleukin-1 Type I \| Receptors, Interleukin-1 Type II \| Receptors, Interleukin-17 \| Receptors, Interleukin-7 \| Receptors, Interleukin-8A \| Receptors, Interleukin-9 \| Receptors, Lymphocyte Homing \| Receptors, OX40 \| Receptors, Thrombopoietin \| Receptors, Tumor Necrosis Factor, Type I \| Receptors, Tumor Necrosis Factor, Type II \| Syndecan-1 \| Transmembrane Activator and CAML Interactor Protein \| Vascular Cell Adhesion Molecule-1 X
URI:	X
Termer och motsvarande begrepp:	CD59-antigeenit (fi) CD59 (fi, ersatt) CD59-antigeeni (fi, ersatt) Antigener, CD59 (sv, ersatt) Antigens, CD59 (en) Protectin (en, ersatt) Membrane Inhibitor of Reactive Lysis (en, ersatt) Membrane Attack Complex Inhibition Factor (en, ersatt) CD59 Antigens (en, ersatt) Homologous Restriction Factor 20 (en, ersatt) HRF20 (en, ersatt) MACIF (en, ersatt) CD59 Antigen (en, ersatt) X
Dela:	X